Literature DB >> 33835136

Squamous cell carcinoma subverts adjacent histologically normal epithelium to promote lateral invasion.

Priyanka Singh1, Rajat Banerjee1, Songlin Piao1, Marcell Costa de Medeiros1, Emily Bellile2, Min Liu1, Dilna Damodaran Puthiya Veettil1, Ligia B Schmitd1, Nickole Russo1, Erika Danella1, Ronald C Inglehart1, Kyriel M Pineault3, Deneen M Wellik3, Greg Wolf4, Nisha J D'Silva1,5,6.   

Abstract

Recurrent and new tumors, attributed in part to lateral invasion, are frequent in squamous cell carcinomas and lead to poor survival. We identified a mechanism by which cancer subverts adjacent histologically normal epithelium to enable small clusters of cancer cells to burrow undetected under adjacent histologically normal epithelium. We show that suppression of DMBT1 within cancer promotes aggressive invasion and metastasis in vivo and is associated with metastasis in patients. Cancer cells via TGFβ1 and TNFα also suppress DMBT1 in adjacent histologically normal epithelium, thereby subverting it to promote invasion of a small population of tumor cells. The sufficiency of DMBT1 in this process is demonstrated by significantly higher satellite tumor nests in Dmbt1-/- compared with wild-type mice. Moreover, in patients, invasion of small tumor nests under adjacent histologically normal epithelium is associated with increased risk for recurrence and shorter disease-free survival. This study demonstrates a crucial role of adjacent histologically normal epithelium in invasion and its important role in the tumor microenvironment and opens new possibilities for therapeutic strategies that reduce tumor recurrence.
© 2021 Singh et al.

Entities:  

Year:  2021        PMID: 33835136     DOI: 10.1084/jem.20200944

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen.

Authors:  Siyu Liu; Emily Bellile; Ariane Nguyen; Katie Zarins; Nisha D'Silva; Laura Rozek; Gregory T Wolf; Maureen A Sartor
Journal:  Oral Oncol       Date:  2021-10-27       Impact factor: 5.337

Review 2.  The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.

Authors:  Michihisa Kono; Shin Saito; Ann Marie Egloff; Clint T Allen; Ravindra Uppaluri
Journal:  Oral Oncol       Date:  2022-07-09       Impact factor: 5.972

3.  Cancer-associated keratinocytes: new members of the microenvironment in head and neck cancer.

Authors:  Erika B Danella; Marcell Costa De Medeiros; Nisha J D'Silva
Journal:  Mol Cell Oncol       Date:  2021-07-01

Review 4.  Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.

Authors:  Riley D Z Mullins; Ananya Pal; Thomas F Barrett; Molly E Heft Neal; Sidharth V Puram
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

5.  Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity.

Authors:  Khoa A Nguyen; Madison J Keith; Stephen B Keysar; Spencer C Hall; Anamol Bimali; Antonio Jimeno; Xiao-Jing Wang; Christian D Young
Journal:  Mol Carcinog       Date:  2022-04-13       Impact factor: 5.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.